Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Oneova 2.5 Tablet

Prescription Icon
Prescription Required

Marketer

Blisson Medica Private Limited

Salt Composition

Letrozole (2.5mg)

Overview Oneova 2.5 Tablet

Postmenopausal women with breast cancer may find relief with Oneova 2.5 mg tablets. This medication can be administered independently or alongside other therapies like surgery or radiotherapy. In advanced breast cancer, it aids in metastasis prevention. Oneova 2.5 mg tablets can be ingested with or without food, always following the physician's prescribed dosage and duration for optimal results. Dosage frequency is tailored to individual needs and determined by the treating oncologist based on the patient's condition. Continuous use, as directed, is crucial. Common side effects include excessive perspiration, weariness, hot flashes, and elevated cholesterol (hypercholesterolemia). Report any concerning side effects to your doctor; management strategies may be available. Prior to commencing treatment, disclose any history of liver or kidney impairment, or osteoporosis. A comprehensive medication review is essential as drug interactions can compromise Oneova's efficacy. Inform your physician if you are pregnant, breastfeeding, or planning to become pregnant. Pre- and during-treatment blood tests may be conducted to assess vitamin D levels and bone density.

Primary Ingredients of Oneova 2.5 Tablet

There is no text provided to rephrase. Please provide the text you wish to have rewritten.

Uses of Oneova 2.5 Tablet

Managing breast cancer

Major Benefits of Oneova 2.5 Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Oneova 2.5 Tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Oneova 2.5 Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Oneova 2.5 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Oneova 2.5mg tablets can be consumed with or without food, although consistent timing is recommended.

How Oneova 2.5 Tablet works:

Oneova 2.5 mg tablets function as an aromatase inhibitor, reducing the body's estrogen production. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions associated with the concurrent use of Oneova 2.5 Tablet and alcohol.

PregnancyPregnancyUNSAFE

Pregnant individuals should absolutely avoid Oneova 2.5 Tablets. Research in both animals and pregnant women reveals substantial risks to fetal development, necessitating consultation with a physician before use.

Breast feedingBreast feedingUNSAFE

Lactation and Oneova 2.5 Tablet are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingUNSAFE

Taking Oneova 2.5 Tablet may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Oneova 2.5mg tablets are considered safe for patients with kidney impairment; no dosage modification is typically necessary. Data on use in individuals with end-stage renal disease is, however, scarce. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Oneova 2.5 mg tablets. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Oneova 2.5 Tablet :

Should you forget a Oneova 2.5 Tablet dose, take it immediately. If your next dose is nearly due, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Oneova 2.5 Tablet

LabelValue
Chemical Category Diphenylmethane-based compound
Developing Habits No.
Type of Therapy Cancer Drugs

FAQs on Oneova 2.5 Tablet

Oneova 2.5 tablets, an aromatase inhibitor, are typically prescribed for postmenopausal women with breast cancer, including those who have undergone surgery or chemotherapy.
Oneova 2.5 (an anti-estrogen medication) lowers estrogen levels by inhibiting the aromatase enzyme, responsible for estrogen production. This is significant because estrogen fuels the growth of certain breast cancers, known as estrogen-dependent cancers. Consequently, reduced estrogen can hinder cancer progression.
For advanced breast cancer or cancer that has spread, continue Oneova 2.5 Tablet until tumor progression. Following tamoxifen or surgery, take Oneova 2.5 Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Oneova 2.5 Tablet followed by three years of tamoxifen may be used.
It's safe to take irbesartan and Oneova 2.5 Tablet concurrently, but monitor your blood pressure closely as Oneova 2.5 Tablet might elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Oneova 2.5 Tablet may cause cataracts. Seek immediate medical attention if you develop blurred vision or eye irritation.
Experiencing hot flushes may indicate a common side effect of Oneova 2.5 Tablet, related to decreased estrogen. These typically lessen as your body adapts, though some may persist throughout treatment and subside afterward. If bothersome, consult your doctor for management options.
While rare, serious side effects of Oneova 2.5 Tablet may include stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Oneova 2.5 Tablet can lead to bone thinning (osteoporosis) resulting from reduced estrogen. Your doctor might monitor your bone density before, during, and after treatment to detect osteoporosis.
The Ministry of Health and Family Welfare restricts Oneova 2.5 Tablet use to ovulation induction in women with anovulatory infertility.
Oneova 2.5 Tablet
221